9. Stock-Based Compensation

During the three months ended March 31, 2026, the Company maintained the VIDA Global Inc. 2022 Equity Incentive Plan (the “Plan”) under which it was able to grant stock options, restricted stock awards, restricted stock units and other equity-based awards to employees, directors, and consultants. As of March 31, 2026, a total of 1,731,211 shares of common stock were reserved for issuance under the Plan, of which 361,652 shares remained available for future grant as of that date.

In April 2026, the Company’s board of directors and stockholders adopted the 2026 Omnibus Equity Incentive Plan (the “2026 Plan”). The 2026 Plan came into existence and became effective upon the effectiveness of the registration statement in connection with the IPO, after which no further grants will be made under the Plan. See Note 14 Subsequent Events for additional information.

Stock Options

Stock options are granted with an exercise price equal to at least the estimated fair value of the Company’s common stock on the date of grant, as determined by the Board of Directors with reference to contemporaneous third-party valuations and other factors. Options generally vest over four years with a one-year cliff and have a contractual term of ten years.

The fair value of stock options is estimated on the grant date using the Black Scholes option pricing model with the following weighted average assumptions:

 Schedule of Assumption of Black-scholes Option Pricing Model

For the three months ended March 31, 2026 and 2025:

A summary of stock option activity under the Plan for the three months ended March 31, 2026 and 2025 is as follows:

 Schedule of Stock Option Activity

During the three months ended March 31, 2026 and 2025, stock-based compensation from stock options totaled $24,787 and $1,715, respectively. For the three months ended March 31, 2026, $12,535 was expensed as a component of sales and marketing expense and $5,337 was expensed as a component of general and administrative expense on the condensed statement of operations while the remaining $6,915 was capitalized as a component of capitalized software costs. For the three months ended March 31, 2025, $1,513 was expensed as a component of sales and marketing expense and $202 was expensed as a component of general and administrative expense on the condensed statement of operations. No amounts were capitalized as a part of capitalized software costs for the three months ended March 31, 2025.

At March 31, 2026 and December 31, 2025, the aggregate intrinsic value of stock options outstanding was approximately $330,000 and $267,000, respectively. At March 31, 2026 and December 31, 2025, the aggregate intrinsic value of stock options exercisable was approximately $33,000 and $23,000, respectively.

As of March 31, 2026, total unrecognized compensation cost related to stock options was $302,919, which is expected to be recognized over a weighted average period of 3.34 years.

Restricted Stock Awards

The Company has also granted restricted common stock awards with varying vesting periods between 10 and 48 months based on continued service. The grant date fair value of these awards is based on the estimated fair value of the Company’s common stock on the grant date. Some of these common stock awards were restricted upon issuance while others were originally issued unrestricted but became restricted subsequent to issuance.

A summary of unvested restricted stock awards for the periods ended March 31, 2026 and 2025 is as follows:

 Schedule of Unvested Restricted Stock Awards

As of March 31, 2026, total unrecognized compensation cost related to unvested restricted stock was $788,613, which is expected to be recognized over a weighted average period of 2.52 years.

During the three months ended March 31, 2026, stock-based compensation from restricted stock totaled $145,637 of which $36,150 was capitalized as a component of capitalized software costs and the remaining $109,487 was expensed as a component of general and administrative expense on the condensed statement of operations. During the three months ended March 31, 2025, stock-based compensation from restricted stock totaled $119,666, of which $66,785 was capitalized as a component of capitalized software costs and the remaining $52,881 was expensed as a component of general and administrative expense on the condensed statement of operations.